Beta Bionics (BBNX) Return on Capital Employed (2025 - 2026)
Beta Bionics recorded quarterly Return on Capital Employed of 26.35% in Q1 2026, down 9.72% quarter-over-quarter from 24.02% in Q4 2025, and down 240.0% year-over-year from 18.82% in Q1 2025.
Beta Bionics' Return on Capital Employed history runs 2 years deep, the most recent figure standing at 26.35% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 240.0% year-over-year to 26.35%; the TTM figure through Mar 2026 stood at 26.35% (down 240.0% YoY), while the FY2025 annual figure was 34.42%, up 721.0% from the prior year.
- Return on Capital Employed came in at 26.35% for Q1 2026 at Beta Bionics, down from 24.02% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 19.88% in Q2 2025 to a low of 26.35% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Beta Bionics | 572.34 Mn | 542.03 Mn | 16.44 Mn | -26.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.35% |
| Dec 31, 2025 | -24.02% |
| Sep 30, 2025 | -22.52% |
| Jun 30, 2025 | -19.88% |
| Mar 31, 2025 | -23.95% |